Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Background. High-dose chemotherapy and stem cell transplantation are being applied increasingly to the treatment of selected patients with multiple myeloma or primary systemic amyloidosis. Stem cell transplantation presents unique challenges to the nephrologist because of the high prevalence of renal involvement in myeloma and the issues that are associated with high-dose chemotherapy in patients with the nephrotic syndrome due to renal amyloid. Methods. We review the published literature on stem cell transplantation in patients with reduced renal function. Results and Conclusions. The specifics of transplantation pertaining to patients with renal amyloid nephrotic syndrome are discussed in detail.

Original languageEnglish (US)
Pages (from-to)1464-1471
Number of pages8
JournalKidney international
Volume68
Issue number4
DOIs
StatePublished - Oct 2005

Keywords

  • High-dose chemotherapy
  • Multiple myeloma
  • Nephrotic syndrome
  • Primary amyloidosis
  • Renal failure
  • Stem cell transplantation

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement'. Together they form a unique fingerprint.

Cite this